Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

maruishi pharmaceutical. co., ltd. - hydrophilic cream - white ointment

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - hydrophilic cream - white ointment

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

maruishi pharmaceutical. co., ltd. - hydrophilic petrolatum - white ointment

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - haemophilus parasuis; thiomersal - misc. vaccines or anti sera - haemophilus parasuis vaccine active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - glassers disease | haemophilus parasuis serovar 13 | haemophilus parasuis serovar 4 | haemophilus parasuis serovar 5 | polyserositis

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - haemophilus type b polysaccharide, quantity: 10 microgram; tetanus protein, quantity: 18 microgram - injection, powder for - excipient ingredients: trometamol; sucrose - for use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the haemophilus influenzae type b.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tetanus toxoid, quantity: 40 microgram/ml; haemophilus influenza type b polyribose ribitol phosphate, quantity: 20 microgram/ml - injection, powder for - excipient ingredients: water for injections; sodium chloride; lactose - hiberix is indicated for active immunisation against haemophilus influenzae type b infection in children aged from 2 months to 5 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - haemophilus type b polysaccharide, quantity: 10 microgram; tetanus protein, quantity: 18 microgram - injection, powder for - excipient ingredients: trometamol; sucrose - for use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the haemophilus influenzae type b.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

crown healthcare (t) ltd, tanzania - syphilis ab rapid diagnostic test -

Philippines - English - FDA (Food And Drug Administration)

sun pharma philippines, inc.; distributor: adp pharma corporation - co-amoxiclav - film-coated tablet - 625mg

Philippines - English - FDA (Food And Drug Administration)

phil pharmawealth, inc.; distributor: phil pharmawealth, inc. - famotidine - lyophilized powder for injection (iv) - 20 mg